Do Drug Ads With Adherence Claims Impact Consumer Perceptions? $722,000 Study Aims To Find Out

Office of Prescription Drug Promotion’s latest study is assessing consumer and physician responses to prescription drug promotions with claims about patient adherence and preference. It is one of 73 research projects OPDP has undertaken.

Drug adherence
Prescription drug ads with claims of patient adherence are subject of new FDA study • Source: Shutterstock

The US Food and Drug Administration’s Office of Prescription Drug Promotion announced its second research project of the year, which builds on previous research on market claims and disclosures and is one of its most expensive with a price tag of $722,644.

The new project, “Adherence Potential and Patient Preferences in Prescription Drug Promotion,” will assess the influence of statements around patient...

More from Marketing & Advertising

More from Compliance